Registration was successful!
Please follow the link from the email sent to

WHO Europe Head Kluge Holds Press Conference in Moscow - Video

© Sputnik / Ilya PitalevAn employee of the National Medical Research Center for Endocrinology of the Russsian Health Ministry in a specially created infectious disease building for treating people with coronavirus
An employee of the National Medical Research Center for Endocrinology of the Russsian Health Ministry in a specially created infectious disease building for treating people with coronavirus - Sputnik International
Subscribe
Hans Kluge previously thanked Russia during a meeting with Health Minister Mikhail Murashko, stressing that the World Health Organisation appreciates the efforts the country has made to develop a vaccine against COVID-19.

Regional Director for Europe at the WHO Hans Kluge held a press conference in Moscow after visiting a telemedical facility, where coronavirus patients with mild symptoms may get professional help without leaving their homes.

Kluge earlier expressed confidence that the ongoing post-registration trials of the Russian vaccine, Sputnik V, will bear positive results as he thanked the country for a safe and effective drug against the coronavirus.

On 11 August, Russia became the first country in the world to officially register a vaccine against COVID-19, developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology. It underwent two successful phases of clinical trials and is now undergoing post-registration trials involving about 42,000 people in Russia and around the world.

Follow Sputnik's Live Feed to Find Out More!

Newsfeed
0
To participate in the discussion
log in or register
loader
Chats
Заголовок открываемого материала